BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37385675)

  • 21. [
    Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
    Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of [
    Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting Fibroblast Activation Proteins in Lymphoma Using
    Jin X; Wei M; Wang S; Wang G; Lai Y; Shi Y; Zhang Y; Yang Z; Wang X
    J Nucl Med; 2022 Feb; 63(2):212-217. PubMed ID: 34049984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast Activation Protein-Targeted PET/CT with
    Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
    J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Luo Y; Pan Q; Zhou Z; Li M; Wei Y; Jiang X; Yang H; Li F
    Radiology; 2023 May; 307(3):e222052. PubMed ID: 36853178
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
    Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [
    Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Chen J; Xu K; Li C; Tian Y; Li L; Wen B; He C; Cai H; He Y
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4064-4076. PubMed ID: 37526694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Potential of Supplemental Static and Dynamic
    Röhrich M; Daum J; Gutjahr E; Spektor AM; Glatting FM; Sahin YA; Buchholz HG; Hoppner J; Schroeter C; Mavriopoulou E; Schlamp K; Grott M; Eichhorn F; Heußel CP; Kauczor HU; Kreuter M; Giesel F; Schreckenberger M; Winter H; Haberkorn U
    J Nucl Med; 2024 Jun; 65(6):872-879. PubMed ID: 38604763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head to head comparison of
    Zhang A; Meng X; Yao Y; Zhou X; Zhang Y; Li N
    Eur Radiol; 2024 Mar; 34(3):1960-1970. PubMed ID: 37668694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Shangguan C; Yang C; Shi Z; Miao Y; Hai W; Shen Y; Qu Q; Li B; Mi J
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):285-294. PubMed ID: 37634891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Comparison of
    Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
    Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.